Skip to content

electroCore, Inc. ECOR Inventory write-downs

Inventory write-downs at other companies

Neuropace, Inc. logo
Neuropace, Inc.NPCE
$76K+72.7%
Avanos Medical logo
Avanos MedicalAVNS
$3.3M+94.1%
Neuronetics logo
NeuroneticsSTIM
-$30K-700%
LivaNova logo
LivaNovaLIVN
$0
Globus Medical logo
Globus MedicalGMED
$4.96M-16.8%
NuSkin Enterprises logo
NuSkin EnterprisesNUS
$4.75M+54.0%

Other financials

Income statement

See full
Revenue$9.6M+42.6%
Gross profit$8.4M+46.6%
Operating income-$5.3M-39.1%
Net income-$5.3M-36.7%
EPS (diluted)-$0.59-25.5%

Balance sheet

See full
Cash & equivalents$4.9M+20.5%
Total debt$9.5M+127%
Total equity-$5.7M-230%
Total assets$15.5M-3.5%

Cash flow

See full
Operating cash flow-$3.0M+30.9%
CapEx$2.0K-94.6%
Free cash flow-$3.0M+31.5%

Valuation

See full
Market cap$71.67M+81.6%
Enterprise value$76.31M+90.2%
P/S2.1×+0.6×

Profitability

See full
Gross margin87.2%+2.0pp
Operating margin-42%-3.3pp
Net margin-44.1%-2.0pp
FCF margin-19.7%

Returns & leverage

See full
Return on equity-210.6%+125pp
Debt / equity3.8×+3.5×
Current ratio-0.5×

Where this comes from

Reported directly by electroCore, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InventoryWriteDown.

The official record: electroCore, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about electroCore, Inc.'s inventory write-downs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is electroCore, Inc.'s inventory write-downs?
electroCore, Inc. (ECOR) reported inventory write-downs of $33K in Q1 2026.
How has electroCore, Inc.'s inventory write-downs changed year-over-year?
electroCore, Inc.'s inventory write-downs increased by 137.5% year-over-year, from -$88K to $33K.
What does inventory write-downs mean?
This represents the reduction in the carrying value of inventory to its net realizable value when market conditions or product utility decline. It reflects management's assessment of inventory valuation risks and potential obsolescence. Consistent write-downs can indicate challenges in inventory turnover or market demand for the company's products.